Endoscopic I-scan Versus Histopathological Evaluation Of Esophageal Lesions
NCT05876702 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2023-05-25
Summary
Considering esophageal diseases, according to a cross-sectional study of endoscopic findings in patients who underwent upper endoscopy at the Fayoum University Hospital, the most common esophageal conditions seen with the endoscope were esophageal varices (25.6% of cases), GERD (23.8% of cases), esophagitis (7.4% of cases), and esophageal monilasis.
GERD is characterized by dystressing symptoms and consequences brought on by the reflux of stomach contents. (Vakil et al., 2006)It appears that the 2 main GERD phenotypes have different pathophysiological and clinical characteristics. In addition, the response to antireflux medication varied significantly between NERD and erosive esophagitis. Patients with NERD made up the majority of the group with refractory heartburn because they had a noticeably lower response rate to proton pump inhibitor (PPI) therapy.
Barrett's oesophagus (BO) and oesophageal adenocarcinoma, may develop as a result of GERD. Barrett's oesophagus is characterised by intestinal metaplasia, which is characterised by acid mucin-containing goblet cells, and the replacement of any length of the squamous epithelium in the distal oesophagus by columnar epithelium.
Dysphagia is frequently brought on by esophageal cancer, which is a serious public health issue. In 2003, there were an estimated 13,900 new instances of esophageal cancer in the US, and 13,000 people passed away from the disease. Only 13% of people survive five years.
High-resolution white-light endoscopy during gastroscopy can identify abnormalities in the mucosa. The endoscopist must decide if the aetiology of erosions, ulcers, strictures, or metaplasia is non-neoplastic or cancerous if they are discovered. Discoloration, a grainy appearance (orange peel effect), and small lumps and depressions in Barrett's layer are indications of dysplasia.
The high-definition I-Scan was created by Pentax (HOYA, Japan) and is based on processing the picture captured by the endoscope's CCD (charge coupled device) to enhance the contrast of the vascular structures and the patterns of the digestive tract's mucosa.(Andrés Reyes-Dorantes, 2011)For the situations outlined below, some authors advise using the I-Scan modes:I-Scan 1 (SE) thought to be used to find lesions. Without affecting the clarity of the endoscopic image, it sharpens the image of minute surface defects,the I-Scan 2 (TE plus SE) imaging system should be utilized to characterize lesions. It increases subtle alterations in the mucosa and vascular architecture while combining surface and tone augmentation and for defining lesions, I-Scan 3 (TE plus CE) should be utilized. The margins of the endoscopic image are darkened and blue colour is digitally added.
In patients with gastrointestinal diseases, endoscopic biopsy and histological evaluation enable early diagnosis of precancerous and cancerous tumours and prompt disease therapy.(Afzal et al., 2006)The results of specimens from a study conducted over five years (2004-2008) in the pathology departments of Cairo University's faculty of medicine and the Theodor Bilharz Research Institute in Egypt were as follows: 54.76% of the 210 esophageal specimens had GERD, 17.61% had Barrett's oesophagus, 3.81% had benign lesions, 18.6% had malignant lesions (squamous cell carcinoma, adenocarcinoma, and undifferentiated carcinoma, each accounting for 10.48% of the total), and 5.24% had other conditions.
Conditions
- Esophageal Lesions
Interventions
- DEVICE
-
endoscopy
use of upper endoscopy with i-scan specially , in diagnosis of esophageal lesions and comparison of results with histopathology.
Sponsors & Collaborators
-
Sohag University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-01
- Primary Completion
- 2024-05-01
- Completion
- 2024-05-01
Countries
- Egypt
Study Locations
More Related Trials
-
One-stop-shop Endoscopy in Reflux-patients: Evaluation of ENT and GI Features
NCT05634187 ·Status: COMPLETED
-
Detection of Minimal Change Esophagitis Using Confocal Laser Endomicroscopy
NCT00954070 ·Status: TERMINATED
-
Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux
NCT00373997 ·Status: COMPLETED ·Phase: PHASE4
-
Detection of Minimal Change Esophagitis by I-scan
NCT01560910 ·Status: COMPLETED
-
Prevalence of Hiatus Hernia in Gastro-Esophageal Reflux Disease Patients Underwent Upper Endoscopy
NCT06155851 ·Status: NOT_YET_RECRUITING
-
Interpretation of Transnasal Esophagoscopy Findings
NCT00372918 ·Status: COMPLETED ·Phase: PHASE4
-
Epithelial Damage in GERD
NCT01867931 ·Status: COMPLETED
-
24 Hour Esophageal and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis
NCT00154570 ·Status: UNKNOWN
-
Acetic Acid for the Detection of Esophageal Neoplasms
NCT04054713 ·Status: SUSPENDED ·Phase: NA
-
Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?
NCT00444145 ·Status: COMPLETED ·Phase: PHASE4
-
Foreshortened Esophagus and Its Surgical Therapy
NCT00507377 ·Status: COMPLETED
-
Endoscopic Findings in Patients With Typical Gastroesophageal Reflux Disease (GERD) Symptoms
NCT00730106 ·Status: COMPLETED
-
The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire
NCT00901004 ·Status: COMPLETED
-
Endoscopic Resection in Gastro-Esophageal Reflux Disease
NCT03357809 ·Status: SUSPENDED ·Phase: NA
-
Epidemiological Studies and Risk Factor Analysis of GERD in Xiamen City
NCT06585176 ·Status: COMPLETED
-
Biology in Patients With Reflux Esophagitis
NCT01194323 ·Status: COMPLETED
-
Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease
NCT01572974 ·Status: TERMINATED
-
Assessment of Esophageal Epithelium Integrity With Mucosal Impedance
NCT02318862 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Upper Esophageal Sphincter Motor Activity in Patients with Extra Esophageal Reflux Symptoms
NCT06773702 ·Status: ACTIVE_NOT_RECRUITING
-
Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD)
NCT03228407 ·Status: UNKNOWN ·Phase: NA
-
Method of Early Diagnosis of Laryngopharyngeal Reflux
NCT04771221 ·Status: COMPLETED ·Phase: NA
-
Endoesophageal Cryotherapy For Ablating Barrett's Esophagus and Early Stage Esophageal Cancer
NCT00628784 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnostic Value of Flexible Spectral Imaging Color Enhancement (FICE) Plus Probe-based Confocal Laser Endomicroscopy (pCLE) for Minimal Change Esophageal Reflux Disease (MERD) Diagnosis
NCT02336100 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study
NCT02081404 ·Status: COMPLETED ·Phase: NA